# Cyanidin-3-O-Glucoside Protects Against Cognitive Impairment in D-Galactose-Induced Aging Mice by Regulating Nrf2 and NF-κB Pathways

**Authors:** Dan Sun, Yishan Bao, Qian Fan, Liang Zhao, Zhifang Fu, Hong Li, Lei Zhao, Hongmei Jiao

PMC · DOI: 10.3390/nu18060992 · Nutrients · 2026-03-20

## TL;DR

Cyanidin-3-O-glucoside (C3G) helps protect against brain aging in mice by reducing oxidative stress and inflammation through specific molecular pathways.

## Contribution

This study reveals the molecular mechanisms by which C3G protects against cognitive decline in aging mice.

## Key findings

- C3G improved cognitive function and reduced hippocampal damage in aging mice.
- C3G enhanced antioxidant activity and reduced pro-inflammatory cytokines.
- C3G modulated Nrf2 and NF-κB pathways to reduce oxidative stress and inflammation.

## Abstract

Background/Objectives: This study aimed to investigate the protective effects and underlying molecular mechanisms of cyanidin-3-O-glucoside (C3G) against cognitive impairment in aging mice induced by D-galactose (D-gal). Methods: Spatial learning and memory, hippocampal histopathology, oxidative stress and inflammatory markers, as well as underlying regulatory pathways, were assessed in C3G-treated D-galactose-induced aging mice via Morris water maze, H&E staining, biochemical assays, qRT-PCR and Western blot. Results: Results showed C3G improved cognitive function by reducing escape latency and increasing target quadrant time along with platform crossings, while also alleviating hippocampal damage. It dose-dependently enhanced total antioxidant capacity and activities of key antioxidant enzymes (GSH-Px and SOD), reduced malondialdehyde, and inhibited pro-inflammatory cytokines (TNF-α, IL-1β and IL-6). At the molecular level, C3G treatment was associated with changes in the Nrf2 and NF-κB pathways at mRNA and protein levels. It enhanced Nrf2 expression and reduced Keap1 expression, accompanied by upregulated mRNA levels of Nqo1 and Hmox1. Meanwhile, C3G decreased IKKβ and p65 protein expression and downregulated mRNA levels of Ikbkb, Nfkb1, and RelA. The combined contribution of these pathways in reducing ROS and inflammation may constitute the molecular basis underlying the neuroprotective effects of C3G. Conclusions: C3G alleviates cognitive dysfunction and brain damage in D-gal-induced aging mice, with effects associated with modulation of Nrf2 and NF-κB pathways. These findings offer preliminary insights for its dietary application in brain aging intervention.

## Linked entities

- **Genes:** GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], KEAP1 (kelch like ECH associated protein 1) [NCBI Gene 9817], NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728], HMOX1 (heme oxygenase 1) [NCBI Gene 3162], IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970], IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970]
- **Chemicals:** cyanidin-3-O-glucoside (PubChem CID 197081), D-galactose (PubChem CID 206), GSH-Px (PubChem CID 168010211), malondialdehyde (PubChem CID 10964), IL-6 (PubChem CID 165368475)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Nqo1 (NAD(P)H dehydrogenase, quinone 1) [NCBI Gene 18104] {aka Dia4, Dtd, Nmo-1, Nmo1, Nmor1, Ox-1}, Rela (Rela proto-oncogene, NFKB subunit) [NCBI Gene 19697] {aka p65, p65 NF-kappa B, p65 NFkB}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Ikbkb (inhibitor of kappaB kinase beta) [NCBI Gene 16150] {aka IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Keap1 (kelch-like ECH-associated protein 1) [NCBI Gene 50868] {aka INRF2, mKIAA0132}, Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Nfe2l2 (nuclear factor, erythroid derived 2, like 2) [NCBI Gene 18024] {aka Nrf2}
- **Diseases:** hippocampal damage (MESH:D000092223), Cognitive Impairment (MESH:D003072), brain damage (MESH:D001925), inflammation (MESH:D007249)
- **Chemicals:** ROS (-), C3G (MESH:C462279), malondialdehyde (MESH:D008315), H&amp;E (MESH:D006371), D-Galactose (MESH:D005690)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028825/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028825/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028825/full.md

---
Source: https://tomesphere.com/paper/PMC13028825